000 | 01928 a2200577 4500 | ||
---|---|---|---|
005 | 20250515054340.0 | ||
264 | 0 | _c20080124 | |
008 | 200801s 0 0 eng d | ||
022 | _a0167-6806 | ||
024 | 7 |
_a10.1007/s10549-006-9481-8 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCatania, Chiara | |
245 | 0 | 0 |
_aFulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre. _h[electronic resource] |
260 |
_bBreast cancer research and treatment _cNov 2007 |
||
300 |
_a97-103 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
650 | 0 | 4 |
_aBreast Neoplasms _xchemistry |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aEmpathy |
650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
650 | 0 | 4 |
_aEstrogen Antagonists _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFulvestrant |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intramuscular |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProgram Evaluation |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 |
_aReceptors, Progesterone _xanalysis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAscione, Gilda | |
700 | 1 | _aAdamoli, Laura | |
700 | 1 | _aDe Pas, Tommaso | |
700 | 1 | _aMedici, Marta | |
700 | 1 | _aFranceschelli, Lucia | |
700 | 1 | _aVerri, Elena | |
700 | 1 | _aMagni, Elena | |
700 | 1 | _aSanna, Giuseppina | |
700 | 1 | _aTorrisi, Rosalba | |
700 | 1 | _aGoldhirsch, Aron | |
700 | 1 | _aNolè, Franco | |
773 | 0 |
_tBreast cancer research and treatment _gvol. 106 _gno. 1 _gp. 97-103 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10549-006-9481-8 _zAvailable from publisher's website |
999 |
_c16821882 _d16821882 |